eCential Robotics

Summary

About

About eCential Robotics

eCential Robotics builds its Op.n platform around a core station that connects to compatible intraoperative 3D C-arms. Surgeons use a touchscreen to plan implant positions and navigate tracked instruments; pre-calibrated, single-use instruments and tracking arrays provide real-time localisation within the surgical images.

A separate mobile station carries the seven-axis robotic arm. The surgeon can handle it collaboratively from the sterile area before it aligns with a planned trajectory, with motion compensation intended to maintain that alignment. This modular arrangement supports navigation and robotic guidance within an implant-agnostic architecture. Technology companies and implant manufacturers can develop applications around the platform, extending the company's hardware and software through procedure-specific partnerships.

PRICE
Range 1Y
Return
High
Low
Updated
DATA: KORTHOS

Products

Timeline

Events

  • 2026-09-01 - Market Signal - eCential Robotics receives Enovis binding acquisition offer

    The offer provides about €176 million in cash consideration at closing, plus up to €35 million in contingent payments tied to milestones. Enovis expects the parties to enter a definitive agreement after the eCential Robotics works-council process and targets a year-end 2026 close. Enovis plans a robotics center of excellence in Grenoble and intends to combine eCential Robotics surgical-automation capability with its ASTRA enabling-technology platform.

    Source
  • 2026-08-26 - Regulatory - eCential Op.n adds FDA-cleared PERLA TL robotic workflow

    FDA submission K261205 was cleared on July 29, 2026 and covers open, minimally invasive and percutaneous pedicle-screw procedures. The robotic reusable instruments couple Spineart PERLA TL screwdrivers and taps to a robotic adaptor for use in navigation or robotic-guidance mode. The cleared workflow is limited to Spineart implants included in the Perla by Spineart software and uses eCential’s separately cleared Op.n platform.

    Source
  • 2021-01-19 - Market Signal - eCential Robotics secures nearly €100 million financing package

    Bpifrance, Sigma Gestion, Med-Innov and the founders supported the equity component. BNP Paribas, Caisse d’Epargne Rhône Alpes and Crédit Agricole provided banking support. The financing backed international growth and production in Grenoble.

    Source

Relations

Relationships

  • Spineart

    Surgical Robotics Integration Partner - Spineart’s FDA-cleared PERLA TL robotic instruments and software operate with eCential Robotics’ Op.n navigation and robotic-guidance platform.